Phase II trial of intravenous palifosfamide in combination with etoposide and carboplatin in patients with small cell lung cancer.

Trial Profile

Phase II trial of intravenous palifosfamide in combination with etoposide and carboplatin in patients with small cell lung cancer.

Planning
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2011

At a glance

  • Drugs Carboplatin; Etoposide; Palifosfamide
  • Indications Small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top